姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Chen,Jun-Hui | Chairman | 2.76% | |
Guang Tian,Hao-Ping | Vice Chairman | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Wu,Shu-Yuan | Managing Director | 1.12% | |
Yang,Wen-Da | Managing Director | 1.80% | |
Lv,Zong-Xian | Managing Director | 1.76% | |
Wan,Wei-Xue | Director | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Shi Dao,Chang-Ming | Director | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Gong,Cheng-Huang | Director | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Ji Fu,Tuo-Ye | Director | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Zhang,Mei-Juan | Director | 50.00% | HE JIANG LIU INVESTMENT CO., LTD. |
Yang,Ming-Zhe | Director | 2.33% | |
Liao,De-Sheng | Director | 1.62% | |
Huang,Jian-Lin | Director | 1.32% | |
Huang,Guo-De | Director | 1.50% | |
Huang,Zheng | Director | 1.78% | |
Wang,You-Ren | Supervisor | 0.31% | |
Liao,De-Zong | Supervisor | 1.36% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 1,313,745 | 2,776,873 | 2,651,419 |
Operating cost | 543,599 | 1,202,525 | 1,167,807 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 770,146 | 1,574,348 | 1,483,612 |
Unrealized profit (loss) on sales of goods | 3,193 | 5,775 | 8,666 |
Realized profit (loss) on sales of goods | 5,775 | 8,666 | 8,320 |
Operating gross profit (loss), net | 772,728 | 1,577,239 | 1,483,266 |
Operating expenses | 638,589 | 1,323,458 | 1,317,700 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 134,139 | 253,781 | 165,566 |
Non-operating income and expenses | 39,074 | 31,281 | 367,482 |
Net profit (loss) before tax | 173,213 | 285,062 | 533,048 |
Income tax expense (benefits) | 29,415 | 71,565 | 98,392 |
Net profit (loss) of ongoing business for the current period | 143,798 | 213,497 | 434,656 |
Profit (loss) of closed units | - | 0 | -13,948 |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 143,798 | 213,497 | 420,708 |
Other comprehensive profit (loss), net | 29,496 | 38,459 | 115,224 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 173,294 | 251,956 | 535,932 |
Net profit (loss) attributable to owners of parent company | 143,798 | 213,497 | 420,708 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | 173,294 | 251,956 | 535,932 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 1 | 2 | 5 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | -99,233 | 239,027 | 167,146 |
Net cash inflows (outflows) from investing activities | -25,914 | -177,095 | 343,049 |
Net cash inflow (outflow) from financing activities | -194,535 | -303,573 | -180,146 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -4,820 | -9,645 | 3,639 |
Increase (decrease) in cash and cash equivalents in the current period | -324,502 | -251,286 | 333,688 |
Beginning balance of cash and cash equivalents | 809,042 | 1,060,328 | 726,640 |
Ending balance of cash and cash equivalents | 484,540 | 809,042 | 1,060,328 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 2,830,224 | 3,041,109 | 3,091,984 |
Non-current asset | 1,557,686 | 1,516,485 | 1,490,601 |
Total asset | 4,387,910 | 4,557,594 | 4,582,585 |
Current liability | 480,999 | 629,300 | 617,811 |
Non-current liability | 223,303 | 257,980 | 306,416 |
Total liability | 704,302 | 887,280 | 924,227 |
share capital | 800,000 | 800,000 | 800,000 |
Equity - secruity token | - | - | - |
capital reserve | - | - | - |
retained earning | 2,920,658 | 2,936,860 | 2,963,363 |
Other equity | -37,050 | -66,546 | -105,005 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 3,683,608 | 3,670,314 | 3,658,358 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 3,683,608 | 3,670,314 | 3,658,358 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 46 | 45 | 45 |